鱼跃医疗：控股子公司CGM产品获欧盟MDR认证

Product Information - The continuous glucose monitoring system (CGM) developed by Jiangsu Yuyue Kailite Biotechnology Co., Ltd., a subsidiary of the company, has obtained EU MDR certification [1] - The certified products include the Anytime 4 and Anytime 5 series CGM devices [2] - The certification is valid from January 27, 2026, to January 26, 2031, and allows for real-time monitoring of interstitial glucose levels [2] Impact Analysis - The certification meets the latest EU market access requirements, enabling sales in countries that recognize EU MDR qualifications [2] - It enriches the company's international product portfolio, enhancing its competitiveness in the diabetes care sector [2] - The certification is expected to facilitate business development in the EU and other countries that recognize MDR certification [2]